Goldman Sachs Group Inc Amicus Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,190,290 shares of FOLD stock, worth $30.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,190,290
Previous 1,482,359 115.22%
Holding current value
$30.6 Million
Previous $14.7 Million 131.7%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$9.55 - $12.09 $16.3 Million - $20.6 Million
1,707,931 Added 115.22%
3,190,290 $34.1 Million
Q2 2024

Aug 13, 2024
BUY
$9.04 - $11.75 $1.27 Million - $1.65 Million
140,469 Added 10.47%
1,482,359 $14.7 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $8.93 Million - $11.1 Million
-780,855 Reduced 36.79%
1,341,890 $15.8 Million
Q4 2023

Feb 13, 2024
SELL
$9.97 - $14.52 $3.94 Million - $5.74 Million
-395,339 Reduced 15.7%
2,122,745 $30.1 Million
Q3 2023

May 14, 2024
BUY
$11.78 - $13.86 $4.66 Million - $5.48 Million
395,339 Added 18.62%
2,518,084 $30.6 Million
Q3 2023

Nov 14, 2023
SELL
$11.78 - $13.86 $3.28 Million - $3.85 Million
-278,037 Reduced 9.94%
2,518,084 $30.6 Million
Q2 2023

May 14, 2024
BUY
$10.72 - $13.3 $9.49 Million - $11.8 Million
885,390 Added 46.34%
2,796,121 $35.1 Million
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $9.49 Million - $11.8 Million
885,390 Added 46.34%
2,796,121 $35.1 Million
Q1 2023

May 14, 2024
BUY
$10.91 - $13.54 $306,603 - $380,514
28,103 Added 1.49%
1,910,731 $21.2 Million
Q1 2023

May 11, 2023
BUY
$10.91 - $13.54 $306,603 - $380,514
28,103 Added 1.49%
1,910,731 $21.2 Million
Q4 2022

May 14, 2024
SELL
$9.89 - $12.7 $1.31 Million - $1.68 Million
-132,668 Reduced 6.58%
1,882,628 $23 Million
Q4 2022

Feb 13, 2023
SELL
$9.89 - $12.7 $1.31 Million - $1.68 Million
-132,668 Reduced 6.58%
1,882,628 $23 Million
Q3 2022

May 14, 2024
BUY
$9.82 - $12.75 $6.31 Million - $8.2 Million
642,826 Added 46.84%
2,015,296 $21 Million
Q3 2022

Nov 10, 2022
BUY
$9.82 - $12.75 $6.31 Million - $8.2 Million
642,826 Added 46.84%
2,015,296 $21 Million
Q2 2022

May 14, 2024
SELL
$6.23 - $11.12 $4.67 Million - $8.34 Million
-750,275 Reduced 35.34%
1,372,470 $14.7 Million
Q2 2022

Aug 15, 2022
SELL
$6.23 - $11.12 $2.9 Million - $5.17 Million
-465,365 Reduced 25.32%
1,372,470 $14.7 Million
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $3.95 Million - $6.25 Million
500,985 Added 37.48%
1,837,835 $17.4 Million
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $7.77 Million - $9.84 Million
-790,905 Reduced 37.17%
1,336,850 $15.4 Million
Q3 2021

Nov 10, 2021
BUY
$8.74 - $11.84 $18.6 Million - $25.2 Million
2,127,755 New
2,127,755 $20.3 Million

Others Institutions Holding FOLD

# of Institutions
313
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email